ライフサイエンスコーパス: topical administration

1 ity in two animal models of glaucoma via the topical administration.

2 g drug delivery to mucosal tissues following topical administration.

3 ice with intact corneas even after 7 days of topical administration.

4 centration of 5 at the back of the eye after topical administration.

5 oprost, is hydrolyzed in the mouse eye after topical administration.

6 yroSpheres provide a platform for paclitaxel topical administration allowing skin drug localization a

7 r the reduction of intraocular pressure upon topical administration and for the reduction of blood pr

8 mpact of biweekly or monthly repeated Mn(2+) topical administration and the pH levels of the Mn(2+) s

9 or the treatment of KS: alitretinoin gel for topical administration; and liposomal daunorubicin, lipo

10 ntered in the cornea and aqueous humor after topical administration, dorzolamide may compromise corne

11 inal neuroprotective effects of systemic and topical administration (eye drops) of GLP-1R agonists in

12 , we demonstrated the feasibility of using a topical administration for Mn(2+) delivery to the visual

13 rch have focused on the development of daily topical administration forms such as gels, toothpastes,

14 ent NAAA inhibitor that is active in vivo by topical administration in rodent models of hyperalgesia

15 has also been used as an analgesic, and its topical administration is approved for the treatment of

16 cient dry eye produced by lacrimal ablation, topical administration of 0.1 nmol CFTRact-K089 3 times

17 Topical administration of 0.5 to 1.5 M MnCl(2) and intra

18 After 1 day, topical administration of 1 M and 1.5 M MnCl(2) rendered

19 eral concentration that can be obtained with topical administration of 2% pilocarpine in the rabbit e

20 Single topical administration of 25 pmol of 12 increased tear v

21 Topical administration of 7,12-dimethylbenz(a)anthracene

22 Topical administration of A and P together, but not sepa

23 To study the effect of topical administration of a fusion protein (PF-MC) made

24 Topical administration of a halofuginone-containing crea

25 ropore lifetime can be prolonged with simple topical administration of a non-specific cyclooxygenase

26 e healing of skin wounds, and the effects of topical administration of a parathyroid hormone-related

27 Trpm8(-/-) compared with wild-type mice and topical administration of a TRPM8 antagonist reduced bli

28 Topical administration of A192621 (500 microg/ear) in (+

29 Topical administration of acitretin may lessen the risk

30 Topical administration of active MMP-9 to dry eye MMP-9

31 Furthermore, topical administration of active recombinant MMP-8 also

32 colleagues demonstrate that early postnatal topical administration of an ataluren-based formulation

33 ratin 14 allele in epidermal stem cells upon topical administration of an inducer, resulting in EBS p

34 Topical administration of anesthetics such as tetracaine

35 Systemic or topical administration of both interleukin-4 (IL-4) and

36 ansiently lowered to pH approximately 4.0 by topical administration of citrate/phosphate (CP) buffers

37 In cats, topical administration of CV-1808 produced a rapid rise

38 The topical administration of CV-1808 produced a rapid rise

39 In a P. aeruginosa rabbit corneal infection, topical administration of DFO-Ga together with gentamici

40 A single topical administration of DNA encoding IL-10 was benefic

41 ion using an inducible promoter activated by topical administration of doxycycline achieved the same

42 We show that systemic and topical administration of EMAP II from the outset of inf

43 also been associated with glaucoma, in that topical administration of glucocorticoids can increase i

44 In this study, the effects of topical administration of HOCl hydrogel (0.05%) on atopi

45 Topical administration of human IgG screened for high ti

46 by a chemical irritant, and is suppressed by topical administration of hydrocortisone.

47 Therefore, topical administration of IgA is no more effective than

48 However, its antagonism with topical administration of IL-1ra preserves ocular immune

49 Topical administration of imiquimod or S-28463 to the fl

50 local inhibition of cytokine signaling using topical administration of INCB018424, a small molecule i

51 Here we show that the topical administration of liposome-DNA mixtures (lipople

52 The topical administration of local anesthesia originally of

53 Topical administration of low doses of tenofovir DF did

54 esults demonstrated the feasibility of using topical administration of Mn(2+) for MEMRI.

55 found a similar neuroprotective effect using topical administration of native GLP-1 and several GLP-1

56 rved in three-dimensional image stacks after topical administration of near-infrared (NIR) dyes as co

57 This work provides proof-of-concept that topical administration of NPs containing siRNA against a

58 Systemic, local, or topical administration of Pep-1 inhibited the expression

59 In contrast, topical administration of PGF2 alpha increased cataract

60 Difference in BP and HR after topical administration of phenylephrine.

61 actor or of peripheral GC action, as well as topical administration of physiologic lipids, normalized

62 imbus were performed before and 1 hour after topical administration of pilocarpine, 1%, in 1 eye of h

63 This study evaluates effects of topical administration of probiotic bacteria of the genu

64 Topical administration of purified syndecan-1 ectodomain

65 ired MSC recruitment that is reversed by the topical administration of recombinant GPNMB protein to t

66 Restoration of injury requires that topical administration of recombinant mMCP-5 occurs with

67 Topical administration of soluble TNF receptor I and IL-

68 Topical administration of SRPK inhibitors dose-dependent

69 We conclude that topical administration of SST has a potent effect in pre

70 m of the study was to test the usefulness of topical administration of SST in preventing retinal neur

71 Topical administration of study medication (fixed-combin

72 HIV prevention strategies, we evaluated the topical administration of tenofovir as used in CAPRISA 0

73 Topical administration of the IFN-alpha 1 plasmid DNA ex

74 The reduction of stromal edema after topical administration of the inhibitors demonstrates th

75 ntly suppressed skin inflammation induced by topical administration of the TLR7 agonist imiquimod.

76 We have reported previously that topical administration of vascular endothelial growth fa

77 In another mouse group, two topical administrations of 1 M Mn(2+) were applied to th

78 lation of the dura were studied after either topical administration or intravenous infusion of rat al

79 e and prevented the development of AA, while topical administration promoted hair regrowth and revers

80 Topical administration provides an attractive route for

81 easing the time intervals of repeated Mn(2+) topical administration reduced the adverse effects cause

82 was greatest at the site of delivery, ocular topical administration resulted in antigen uptake in the

83 eptide (500 microg) was reduced by as single topical administration sangre de grado balm (1% concentr

84 r replication and vaccine efficacy following topical administration to the respiratory tract of Afric

85 retina showed no injury 1 week after Mn(2+) topical administrations to each mouse.

86 Reporter gene expression following topical administration was largely confined to the super

87 In groups C and EP, topical administrations were performed using a sham susp

88 ry viral replication in rhesus monkeys after topical administration, which was 40-fold lower than tha